A growing tally of issues at the Nippon Dynawave paper mill have come to light since the fatal disaster in May.

Global AI adoption reached 17.8%, but the Global North-South AI gap widened. UAE leads national AI usage, while Asian markets show accelerating generative AI adoption. AI coding tools boosted Git ...

A report compiled by the tech giant Microsoft shows most Central Asian states rank among the lowest in the world in terms of citizens integrating generative artificial intelligence into their daily ...

Donut Lab’s miraculous solid state battery, promising energy density, charging and durability numbers unseen by the industry, has been subject to a criminal complaint in Finland from an insider who ...

The federal government’s disease-tracking agency has paused its diagnostic testing for rabies, monkeypox and a number of other infectious diseases. The Centers for Disease Control and Prevention this ...

CHICAGO (WLS) -- The Illinois Forensic Science Commission is responding to a drug testing scandal, first uncovered by the ABC7 I-Team, at the University of Illinois-Chicago. Many Illinois marijuana ...

If you were to buy a new laptop, you'd have a hard time finding one with a built-in disc drive that can read CDs, DVDs, or Blu-ray discs. That's been the case for years, with Apple famously starting ...

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate. Last month, the agency knocked back an approval application for ...

Mercury 2, the first diffusion-based reasoning large language model, introduces a new approach to token generation by refining multiple tokens in parallel rather than sequentially. This shift enables ...

Long before modern UFO stories, an ancient account describes something terrifyingly specific: “they saw a fiery disc in the sky.” The text claims it had “no head,” made no sound, and even “emitted a ...

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...